Heart pump increases survival in STEMI-related cardiogenic shock

Nature Reviews Cardiology, Published online: 23 April 2024; doi:10.1038/s41569-024-01035-9Data from the DanGer Shock trial demonstrate that implantation of a microaxial flow pump in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock increases the survival rate compared with standard care alone.

https://www.nature.com/articles/s41569-024-01035-9

Source: Nature Reviews Cardiology - April 23, 2024 Category: Cardiology Authors: Jennifer Harman Source Type: research

More News: Cardiogenic Shock | Cardiology | Heart | Heart Attack